Ignite Creation Date:
2024-05-06 @ 1:34 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04054817
Status:
COMPLETED
Last Update Posted:
2023-04-19
First Post:
2019-08-09
Brief Title:
ACRO Biocornea Clinical Trial in Taiwan
Sponsor:
ACRO Biomedical Co Ltd
Organization:
ACRO Biomedical Co Ltd
Study Overview
Official Title:
A Multicenter Open-label Single-arm Study Assess the Collagen Ophthalmic Matrix for Anterior Lamellar Keratoplasty
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to investigate the safety and clinical performance of ABCcolla Collagen Ophthalmic Matrix used for anterior lamellar keratoplasty in patients suffering from corneal ulcer
Participants will undergo keratoplasty using the investigational product and be followed up for 24-week observation total of 10 times
Participants will undergo keratoplasty using the investigational product and be followed up for 24-week observation total of 10 times
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None